• Return to Headlines

Relatively High Forward Earnings Yield Detected in Shares of Pdl Biopharma In in the Biotechnology Industry (PDLI, UTHR, CELG, BIIB, GILD)

By Nick Russo

Below are the three companies in the Biotechnology industry with the highest forward earnings yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a stock's return vs. owning a similar stock or other yield assets (e.g. bonds). Generally, the higher the earnings yield, the more undervalued the stock.

Pdl Biopharma In ranks highest with a forward earnings yield of 22.7%. Following is United Therapeut with a forward earnings yield of 11.6%. Celgene Corp ranks third highest with a forward earnings yield of 9.7%.

Biogen Inc follows with a forward earnings yield of 9.7%, and Gilead Sciences rounds out the top five with a forward earnings yield of 8.8%.

SmarTrend recommended that its subscribers protect gains by selling shares of Gilead Sciences on February 6th, 2018 by issuing a Downtrend alert when the shares were trading at $78.76. Since that call, shares of Gilead Sciences have fallen 6.8%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: highest forward earnings yield pdl biopharma in united therapeut celgene corp biogen inc Gilead Sciences

Ticker(s): PDLI UTHR CELG BIIB GILD